About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in San Antonio | 221 Studies

Clinical Trials Breast CancerSan Antonio

Breast Cancer Clinical Trials in San Antonio

Find 221 clinical trials for breast cancer near San Antonio, Texas. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in San Antonio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 201-220 of 221 trials

CompletedRedes III Patient Navigator Qol StudyThis proposed 5-year Redes En Acción research study involves a mixed-methods approach that occurs in two phases across two distinct and diverse HL communities.NCT02275754·Chicago, Illinois and 1 other CompletedStudy of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast CancerThe primary objective of this study is to assess and compare the efficacy and safety of sacituzumab govitecan-hzi versus treatment of physician's choice (TPC) in participants with…NCT03901339·Avondale, Arizona and 112 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingTamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast CancerThis randomized phase III clinical trial studies how well tamoxifen citrate, anastrozole, letrozole, or exemestane with or without chemotherapy work in treating patients with…NCT01272037·Anniston, Alabama and 1567 others

Active not recruitingA Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast CancerThe main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy in participants with early breast cancer that is estrogen receptor…NCT05514054·Daphne, Alabama and 671 others

Active not recruitingTrastuzumab + Alpelisib +/- Fulvestrant vs Trastuzumab + CT in Patients With PIK3CA Mutated Previously Treated HER2+ Advanced BrEasT Cancer (ALPHABET)Randomized phase III trial of trastuzumab + Alpelisib +/- fulvestrant versus trastuzumab + chemotherapy in patients with PIK3CA mutated previously treated HER2+ Advanced Breast…NCT05063786·Innsbruck and 105 others

CompletedImpact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese SubjectsAssess the impact of dietary omega 3 free fatty acids and/or letrozole on obese, postmenopausal breast cancer patients.NCT02538484·Houston, Texas and 1 other

UnknownEvaluation of a Self-Care Toolkit in Surgical Breast Cancer PatientsThis randomized controlled trial (RCT) in newly-diagnosed breast cancer patients seeks to determine the effectiveness of a self-care toolkit on specific symptoms associated with…NCT02387320·Fort Hood, Texas and 1 other

TerminatedA Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-0587 as a Monotherapy and in Combination With Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast CancerThis is a first-in-human, Phase Ia/Ib, dose-escalation and expansion study evaluating the safety, pharmacokinetics, and activity of GDC-0587 (cyclin-dependent kinase-4 \[CDK4\]…NCT07214662·Grand Rapids, Michigan and 3 others

CompletedS9630, Medroxyprogesterone in Treating Women With Breast CancerRATIONALE: It is not yet known whether medroxyprogesterone is effective in preventing endometrial disorder in patients with breast cancer who are taking tamoxifen.NCT00002920·Mobile, Alabama and 121 others

TerminatedBintrafusp Alfa in High Mobility Group AT-Hook 2 (HMGA2) Expressing Triple Negative Breast CancerThe main purpose of this study was to evaluate bintrafusp alfa monotherapy in participants with triple negative breast cancer (TNBC) who express high levels of HMGA2 as determined…NCT04489940·Newark, Delaware and 44 others

RecruitingA Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid TumorsThis is a Phase 1b/2, Open-label Study to Investigate the Safety and Efficacy of Invikafusp alfa (STAR0602), a Selective T Cell Receptor (TCR)-targeting, Bifunctional…NCT06827613·Los Angeles, California and 7 others

CompletedA Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post MenopauseThe purpose of this study is to learn about the effects of the study medicine PF-07220060 plus letrozole, compared with the effects of taking letrozole alone without PF-07220060…NCT06465368·Barrington, Illinois and 50 others

CompletedNBRST: Prospective Neo-adjuvant REGISTRY TrialThe scope of this registry study is to measure chemosensitivity as defined by pCR (primary endpoint), or endocrine sensitivity as defined by partial response (decrease in longest…NCT01479101·Glendale, Arizona and 75 others

WithdrawnBreast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)This will be a single arm, non-randomized, pre-surgical clinical trial of women with newly diagnosed triple negative breast cancer with high g-H2Ax (gamma H2AX antibodies)…NCT06246786·San Antonio, Texas

RecruitingFirst in Human Study of TUB-030 in Patients With Advanced Solid TumorsThe goal of this clinical trial is to learn if the drug TUB-030 works to treat solid cancer in adults. The study will also explore the safety of TUB-030.NCT06657222·New Haven, Connecticut and 19 others

RecruitingPhase 1 Study of OP-3136 in Advanced or Metastatic Solid TumorsThis is a first-in-human, open-label, multicenter phase 1 study to evaluate safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of…NCT06784193·Sarasota, Florida and 7 others

TerminatedStudy Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7)The HERMIONE-7 trial is a phase II, single-arm, open-label, multicenter study in HR+, HER2- advanced breast cancer patients who have received HD-FUL as first-line endocrine…NCT04227327·Ancona and 38 others

Active not recruitingHormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)This randomized phase III trial studies the best individual therapy for women who have node-negative, estrogen-receptor positive breast cancer by using a special test (Oncotype…NCT00310180·Anniston, Alabama and 1221 others

Active not recruitingNivolumab and Ipilimumab in Treating Patients With Rare TumorsThis phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors.NCT02834013·Birmingham, Alabama and 1006 others

CompletedEffects of Creatine Supplementation in Breast Cancer SurvivorsThe purpose of this study is to test the hypothesis that creatine will accelerate adaptations associated with exercise in breast cancer survivors recently completing chemotherapy.NCT04207359·San Antonio, Texas

PreviousPage 11 of 12Next

Other Conditions in San Antonio

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma